Abstract:Purpose: Brain tumors, particularly glioblastoma multiforme (GBM), present significant prognostic challenges despite multimodal therapies, including surgical resection, chemotherapy, and radiotherapy. One major obstacle is the limited drug delivery across the blood-brain barrier (BBB). Focused ultrasound (FUS) combined with systemically administered microbubbles has emerged as a non-invasive, targeted, and reversible approach to transiently open the BBB, thus enhancing drug delivery. This review examines clinical trials employing BBB opening techniques to optimise pharmacotherapy for brain tumors, evaluates current challenges, and proposes directions for further research. Methods: A systematic literature search was conducted in PubMed and ClinicalTrials.gov up to November 2023, searching for "ultrasound" AND "brain tumor". The search yielded 1446 results. After screening by title and abstract, followed by full-text screening (n = 48), 35 studies were included in the analysis. Results: Our analysis includes data from 11 published studies and 24 ongoing trials. The predominant focus of these studies is on glioma, including GMB and astrocytoma. One paper investigated brain metastasis from breast cancer. Evidence indicates that FUS facilitates BBB opening and enhances drug uptake following sonication. Exploration of FUS in the pediatric population is limited, with no published studies and only three ongoing trials dedicated to this demographic. Conclusion: FUS is a promising strategy to safely disrupt the BBB, enabling precise and non-invasive lesion targeting, and enhance drug delivery. However, pharmacokinetic studies are required to quantitatively assess improvements in drug uptake. Most studies are phase I clinical trials, and long-term follow-up investigating patient outcomes is essential to evaluate the clinical benefit of this treatment approach. Further studies involving diverse populations and pathologies will be beneficial.

Low-intensity ultrasound: A novel technique for adjuvant treatment of gliomas

Low-Intensity Focused Ultrasound Technique in Glioblastoma Multiforme Treatment.

Translational Prospects of Ultrasound-Mediated Tumor Immunotherapy: A Review of Preclinical Advances and Safety Considerations.

Ultrasound inhibits tumor growth and selectively eliminates malignant brain tumor in vivo

Targeted Delivery of Liposomal Temozolomide Enhanced Anti-Glioblastoma Efficacy through Ultrasound-Mediated Blood–Brain Barrier Opening

Low-intensity ultrasound combined with arsenic trioxide induced apoptosis of glioma via EGFR/AKT/mTOR

Progression in low-intensity ultrasound-induced tumor radiosensitization

Focused Ultrasound Strategies for Brain Tumor Therapy

Accurately Controlled Delivery of Temozolomide by Biocompatible UiO-66-NH 2 Through Ultrasound to Enhance the Antitumor Efficacy and Attenuate the Toxicity for Treatment of Malignant Glioma.

Progress in the application of ultrasound in glioma surgery

Focused Ultrasound-Mediated Small-Molecule Delivery to Potentiate Immune Checkpoint Blockade in Solid Tumors

Focused ultrasound-mediated enhancement of blood-brain barrier permeability for brain tumor treatment: a systematic review of clinical trials

The impact of low intensity ultrasound on cells: Underlying mechanisms and current status

Current Status and Future Perspectives of Sonodynamic Therapy in Glioma Treatment.

Focused ultrasound as a treatment modality for gliomas

Translation of focused ultrasound for blood-brain barrier opening in glioma

Effects of low-intensity ultrasound opening the blood-brain barrier on Alzheimer's disease—a mini review

Opening of the Blood–Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models

Ursolic Acid Nanoparticles for Glioblastoma Therapy

Progress and prospect in tumor treating fields treatment of glioblastoma

Ultrasound-assisted brain delivery of nanomedicines for brain tumor therapy: advance and prospect